UsAgainstAlzheimer’s Statement on Initial Findings from Novo Nordisk Alzheimer’s EVOKE and EVOKE+ Trials

UsAgainstAlzheimer’s released the following statement after Novo Nordisk announced results from its phase 3 EVOKE and EVOKE+ trials.

This November, we’re honoring Alzheimer’s Awareness Month.

Understand your brain health today — and take the first step with BrainGuide.

UsAgainstAlzheimer’s Applauds Senate Appropriators for Robust Investments in Alzheimer’s Programs

These significant investments in research underscore the millions of Americans impacted by Alzheimer’s and other dementias.

UsAgainstAlzheimer’s Launches Clinical Trial Connector to Improve Access to Alzheimer’s Research

UsAgainstAlzheimer's announced the launch of the BrainGuide Clinical Trial Connector, a free, confidential tool developed in partnership with Carebox. This new resource helps individuals, caregivers, and healthcare providers easily find and connect with clinical trials for Alzheimer’s disease and related dementias (ADRD).

Join the UsAgainstAlzheimer's Membership Program

Become a Member of UsAgainstAlzheimer's today and join a movement of people who don’t just talk about the Alzheimer’s crisis, but become part of the solution.

Statement on Initial Findings from Novo Nordisk Alzheimer’s EVOKE and EVOKE+ Trials

Early detection can change lives.

UsAgainstAlzheimer’s Applauds Robust Investments in Alzheimer’s Programs

UsAgainstAlzheimer’s Launches Clinical Trial Connector to Improve Access to Alzheimer’s Research

Become a Member

VISION: UsAgainstAlzheimer's envisions a world without Alzheimer's where brainspan equals lifespan. 

MISSION: Catalyze change in the health ecosystem to improve dementia prevention, early detection, and access to treatments through advocacy, policy, convening, and high-leveraged programs, with a particular focus on health equity.   

 

Prevention

Alzheimer’s is not a normal part of aging. There are things we can all do to reduce our risk, like eating a healthy diet, exercising, and getting good sleep. People need to know what’s good for the body is good for the brain. Learn more about our prevention work and how you can take charge of your brain health.

CLICK HERE FOR MORE INFO

Early Detection & Diagnosis

Early detection and diagnosis give people a better chance of managing the disease. On top of that, current treatments are most effective with patients in the early stages of dementia.

Find out how we are raising awareness of the importance of early detection and how BrainGuide is helping people concerned about their brain health start a conversation with their doctor.

CLICK HERE FOR MORE INFO

Access to Treatments

We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer’s patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.

See how else UsAgainstAlzheimer’s is fighting for access to treatments.

CLICK HERE FOR MORE INFO

 

Center for Brain Health Equity

Most Alzheimer’s patients are women, Latinos, and Black people. As a patient-centered organization, all our work is done with equity in mind, so we are addressing needs of the people who are most heavily impacted by the disease. Learn more about how UsAgainstAlzheimer’s Center for Brain Health Equity is working toward a healthcare system that works for everyone.

Recent News and Blog Posts

  • October 13, 2023

    UsAgainstAlzheimer’s Celebrates CMS Decision to Expand Medicare Coverage for Additional PET Scans

    Policy change allows for earlier diagnosis for millions of seniors and better...

    Read more
  • August 16, 2023

    UsAgainstAlzheimer’s Urges CMS to Adopt Proposed Policy That Removes Restrictions on Medicare Coverage of PET Scans for Alzheimer’s Patients

     Increased coverage would provide Alzheimer’s patients and their families with more...

    Read more
  • July 21, 2023

    UsAgainstAlzheimer’s Statement on Tony Bennett’s Death

    UsAgainstAlzheimer’s chair and co-founder George Vradenburg released a statement on the death...

    Read more
  • July 18, 2023

    CMS Proposes Removal of Policy That Limits Medicare Coverage of PET Scans for Alzheimer’s Patients

    Proposal would make Medicare coverage of Leqembi possible for millions while increasing...

    Read more
  • July 18, 2023

    Hearing Aids and Other Technologies Slowed Cognitive Decline by 48%, Study Shows

    Hearing loss is one of six major risk factors associated with Alzheimer’s 

    Read more
  • July 17, 2023

    New Donanemab Data Demonstrates Momentum Toward Choice of Treatments for Alzheimer’s Patients

    Research shows no clinical progression for nearly half of early-stage patients at...

    Read more

Reports

  • Resources
    report

    2024 Annual Report

  • Resources
    2023 report

    2023 Annual Report

  • Resources

    2022 Annual Report